TrialThe Journal of antimicrobial chemotherapy2021

Pharmacokinetic/pharmacodynamic investigation of raltegravir with or without lamivudine in the context of HIV-1 pre-exposure prophylaxis (PrEP).

Carolina Herrera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.